TB-500's Role in Biotech R&D Growth SHERIDAN, WY / ACCESS Newswire / December 12, 2025 / From 2024 to 2027, biotech R&D ...

Officials at India-based Syngene International, a CRDMO, report that the company executed site upgrades to accelerate drug discovery and development. The investments included a dedicated peptide ...

Grace & Co. (Grace), a Standard Industries company and leading global supplier of specialty chemicals and solutions that enable industries to enhance modern life, and Molecule.one, a global leader in ...

BioDuro, a research and CDMO group, opened a new peptide synthesis manufacturing facility at its campus in the Zhangjiang tech center in Shanghai. The facility expands the company’s peptide synthesis ...

Amide Technologies has raised $16.5 million in venture capital to help commercialize its peptide production process. The process was developed from 2011 to 2017 in the lab of the Massachusetts ...

Public interest in the Wolverine peptide stack has accelerated rapidly throughout 2025, becoming one of the most discussed topics in the peptide research ecosystem. In response, WolverinePeptideStack.

Novo Nordisk is spending $6 billion in Kalundborg, Denmark, to expand the production of active pharmaceutical ingredients (APIs), including peptides used in weight-loss and antidiabetic drugs. The ...

Using super-resolution microscopy, Assistant Professor Samy Lamouille discovered an association in the brain cancer glioblastoma between the protein connexin 43, shown in green, and parts of cells ...

BENGALURU and HYDERABAD, India, Oct. 17, 2025 /PRNewswire/ -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to ...